
Core Drugs & Research Private Limited
Founded in 2012 and headquartered in Madhya Pradesh, India.
Founded in 2012 and headquartered in Madhya Pradesh, India.
Indore, Madhya Pradesh, India
+91-XXXXXXXXXX
-
U85190MP2012PTC029411
029411
Private Limited Indian Non-Government Company
19 Oct 2012
-
-
Unlisted
Roc Gwalior
Name | Designation | Appointment Date | Status |
---|---|---|---|
Pankaj Joshi ![]() | Director | 19-Oct-2012 | Current |
Mohammad Ali ![]() | Director | 19-Oct-2012 | Current |
Ratan Mishra ![]() | Director | 19-Oct-2012 | Current |
Enhance accessibility to Core Drugs & Research's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
Unlock access to Core Drugs & Research's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Pankaj Joshi is a mutual person
Mohammad Ali is a mutual person
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Core Drugs & Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Core Drugs & Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Core Drugs & Research's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Pankaj Joshi was appointed as a Director was appointed as a Director on 19 Oct 2012 & has been associated with this company since 12 years 4 months .
19 Oct 2012
Mohammad Suhaib Ali was appointed as a Director was appointed as a Director on 19 Oct 2012 & has been associated with this company since 12 years 4 months .
19 Oct 2012
Ratan Mishra was appointed as a Director was appointed as a Director on 19 Oct 2012 & has been associated with this company since 12 years 4 months .
19 Oct 2012
Core Drugs & Research Private Limited was registered on 19 Oct 2012 with Roc Gwalior & aged 12 years 4 months as per MCA records.
19 Oct 2012
Core Drugs & Research Private Limited was incorporated on 19 Oct 2012.
The authorized share capital of Core Drugs & Research Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.
Currently 3 directors are associated with Core Drugs & Research Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Core Drugs & Research Private Limited is 206 Fortune Business Center 165 Rnt, Marg India, Indore, Madhya Pradesh, 452001.
The corporate identification number (CIN) of Core Drugs & Research Private Limited is U85190MP2012PTC029411 and the company number is 029411 as per Ministry of Corporate Affairs (MCA).